JP2022088631A5 - - Google Patents

Download PDF

Info

Publication number
JP2022088631A5
JP2022088631A5 JP2022062741A JP2022062741A JP2022088631A5 JP 2022088631 A5 JP2022088631 A5 JP 2022088631A5 JP 2022062741 A JP2022062741 A JP 2022062741A JP 2022062741 A JP2022062741 A JP 2022062741A JP 2022088631 A5 JP2022088631 A5 JP 2022088631A5
Authority
JP
Japan
Prior art keywords
bacterial strain
composition according
rrna gene
gene sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022062741A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022088631A (ja
Filing date
Publication date
Priority claimed from GBGB1810386.1A external-priority patent/GB201810386D0/en
Priority claimed from GBGB1813460.1A external-priority patent/GB201813460D0/en
Priority claimed from GBGB1817642.0A external-priority patent/GB201817642D0/en
Priority claimed from GBGB1820264.8A external-priority patent/GB201820264D0/en
Priority claimed from GBGB1820256.4A external-priority patent/GB201820256D0/en
Priority claimed from PCT/EP2019/062238 external-priority patent/WO2019215346A1/en
Application filed filed Critical
Publication of JP2022088631A publication Critical patent/JP2022088631A/ja
Publication of JP2022088631A5 publication Critical patent/JP2022088631A5/ja
Pending legal-status Critical Current

Links

JP2022062741A 2018-05-11 2022-04-05 細菌株を含む組成物 Pending JP2022088631A (ja)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
EP18171893.3 2018-05-11
EP18171893 2018-05-11
EP18178136 2018-06-15
EP18178136.0 2018-06-15
GB1810386.1 2018-06-25
GBGB1810386.1A GB201810386D0 (en) 2018-06-25 2018-06-25 Compositions comprising bacterial strains
GBGB1813460.1A GB201813460D0 (en) 2018-08-17 2018-08-17 Compositions comprising bacterial strains
GB1813460.1 2018-08-17
GBGB1817642.0A GB201817642D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GB1817642.0 2018-10-29
GB1820264.8 2018-12-12
GBGB1820264.8A GB201820264D0 (en) 2018-12-12 2018-12-12 Compositions comprising bacterial strains
GBGB1820256.4A GB201820256D0 (en) 2018-12-12 2018-12-12 Compositions comprising bacterial strains
GB1820256.4 2018-12-12
PCT/EP2019/062238 WO2019215346A1 (en) 2018-05-11 2019-05-13 Compositions comprising bacterial strains
JP2020545563A JP7058449B2 (ja) 2018-05-11 2019-05-13 細菌株を含む組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020545563A Division JP7058449B2 (ja) 2018-05-11 2019-05-13 細菌株を含む組成物

Publications (2)

Publication Number Publication Date
JP2022088631A JP2022088631A (ja) 2022-06-14
JP2022088631A5 true JP2022088631A5 (https=) 2022-06-28

Family

ID=66597549

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020562128A Pending JP2021523895A (ja) 2018-05-11 2019-05-13 細菌株を含む組成物
JP2020545563A Expired - Fee Related JP7058449B2 (ja) 2018-05-11 2019-05-13 細菌株を含む組成物
JP2022062741A Pending JP2022088631A (ja) 2018-05-11 2022-04-05 細菌株を含む組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2020562128A Pending JP2021523895A (ja) 2018-05-11 2019-05-13 細菌株を含む組成物
JP2020545563A Expired - Fee Related JP7058449B2 (ja) 2018-05-11 2019-05-13 細菌株を含む組成物

Country Status (23)

Country Link
US (3) US11419902B2 (https=)
EP (4) EP4066845A1 (https=)
JP (3) JP2021523895A (https=)
KR (2) KR20210008393A (https=)
CN (2) CN112601534A (https=)
AU (3) AU2019267170A1 (https=)
BR (1) BR112020022833A2 (https=)
CA (2) CA3099209A1 (https=)
CY (1) CY1125211T1 (https=)
DK (1) DK3743086T3 (https=)
ES (1) ES2916601T3 (https=)
HR (1) HRP20220578T1 (https=)
IL (1) IL278471B2 (https=)
LT (1) LT3743086T (https=)
MD (1) MD3743086T2 (https=)
MX (1) MX2020012061A (https=)
PL (1) PL3743086T3 (https=)
RS (1) RS63273B1 (https=)
SG (2) SG11202011031UA (https=)
SI (1) SI3743086T1 (https=)
SM (1) SMT202200217T1 (https=)
TW (2) TW202014513A (https=)
WO (2) WO2019215346A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA47439A (fr) 2017-01-31 2019-12-11 Univ Kansas State Cellules microbiennes, leurs procédés de production, et leurs utilisations
TWI812624B (zh) 2017-06-14 2023-08-21 南韓商希杰生物科技股份有限公司 包含細菌品系之組成物
WO2019079764A1 (en) 2017-10-20 2019-04-25 Ms Biotech, Inc. METHODS FOR PRODUCING PLANT MATERIALS EMITTED WITH MEGASPHAERA ELSDENII
SG11202011031UA (en) * 2018-05-11 2020-12-30 4D Pharma Res Ltd Compositions comprising bacterial strains
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
TW202038977A (zh) * 2018-12-12 2020-11-01 英商4D製藥研究有限公司 包含細菌菌株之組成物
WO2020120714A1 (en) * 2018-12-12 2020-06-18 4D Pharma Research Limited Compositions comprising bacterial strains
WO2021252861A1 (en) * 2020-06-11 2021-12-16 Evelo Biosciences, Inc. Compositions and methods for treating diseases and disorders using megasphaera sp
CN112980878B (zh) * 2021-02-04 2023-03-31 中国农业科学院兰州兽医研究所 Hdac8基因敲除的bhk-21细胞系及其构建方法和应用
CN112877275B (zh) * 2021-02-04 2023-03-31 中国农业科学院兰州兽医研究所 Hdac2基因敲除的bhk-21细胞系及其构建方法和应用
WO2023208225A1 (zh) 2022-04-28 2023-11-02 慕恩（广州）生物科技有限公司 药物组合物、巨球型菌及其应用
WO2023208223A1 (zh) 2022-04-28 2023-11-02 慕恩（广州）生物科技有限公司 药物组合物、巨球型菌及其应用
KR102551061B1 (ko) * 2022-05-26 2023-07-03 중앙대학교 산학협력단 Saha를 유효성분으로 포함하는 살모넬라 속 균주에 의한 바이오필름 생성 저해용 조성물
CN117018036B (zh) * 2023-07-28 2025-09-05 深圳未知君生物科技有限公司 巨球形菌属细菌在制备治疗癌症的药物中的应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5557520A (en) * 1978-10-26 1980-04-28 Nisshin Flour Milling Co Ltd Preparation of carcinostatic substance
WO2002080947A1 (fr) 2001-04-06 2002-10-17 Kyodoken Institute For Animal Science Research & Development Compositions contenant une bacterie pouvant convertir de l'acide lactique en acide butyrique, et methode utilisant ces compositions pour prevenir ou traiter l'hyperlactacidemie dans le systeme digestif ou le cancer du colon
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
US20040005304A1 (en) 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
GB0307026D0 (en) * 2003-03-27 2003-04-30 Rowett Res Inst Bacterial supplement
CA2535889A1 (en) 2003-08-29 2005-03-17 Aton Pharma, Inc. Combination methods of treating cancer
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CA3212215A1 (en) 2012-11-23 2014-05-30 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
HK1218560A1 (zh) 2013-02-04 2017-02-24 Seres Therapeutics, Inc. 组成与方法
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP3021853A1 (en) * 2013-07-18 2016-05-25 Baylor College Of Medicine Method of enhancing potency of immune cells
CN104415060A (zh) * 2013-08-30 2015-03-18 深圳华大基因科技有限公司 可食用组合物及其制备方法和用途
US10203329B2 (en) * 2013-09-12 2019-02-12 The Johns Hopkins University Biofilm formation to define risk for colon cancer
EP3074027B1 (en) 2013-11-25 2024-12-18 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US9650654B2 (en) * 2014-06-25 2017-05-16 William Marsh Rice University Making C4+ products in bacteria
US10366793B2 (en) * 2014-10-21 2019-07-30 uBiome, Inc. Method and system for characterizing microorganism-related conditions
WO2016073381A1 (en) * 2014-11-03 2016-05-12 Cerus Corporation Compositions and methods for improved car-t cell therapies
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
CN107405321A (zh) * 2015-01-23 2017-11-28 坦普尔大学 短链脂肪酸在癌症预防中的应用
US20180078587A1 (en) 2015-03-18 2018-03-22 Trustees Of Tufts College Compositions and methods for preventing colorectal cancer
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
HK1254843B (zh) * 2015-11-20 2020-04-17 希杰生物科技株式会社 包含细菌菌株的组合物
US20190247447A1 (en) * 2015-11-24 2019-08-15 Seres Therapeutics, Inc. Designed bacterial compositions
WO2017122197A1 (en) * 2016-01-11 2017-07-20 3Plw Ltd. Lactic acid-utilizing bacteria genetically modified to secrete polysaccharide-degrading enzymes
CN107028985A (zh) * 2016-02-04 2017-08-11 深圳华大基因研究院 厚壁菌类益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
US20190125808A1 (en) * 2016-03-30 2019-05-02 The Trustees Of Columbia University In The City Of New York Methods of preventing, treating and detecting colorectal cancer using butyrate producing bacteria
US9999641B2 (en) * 2016-06-14 2018-06-19 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
JP7542946B2 (ja) * 2016-09-27 2024-09-02 ボード オブ リージェンツ， ザ ユニヴァーシティー オブ テキサス システム マイクロバイオームをモジュレートすることにより、免疫チェックポイント遮断療法を増強するための方法
US11571446B2 (en) 2016-11-18 2023-02-07 Sanford Bumham Prebys Medical Discovery Institute Gut microbiota and treatment of cancer
US20190314427A1 (en) 2016-12-16 2019-10-17 Evelo Biosciences, Inc. Methods of treating cancer using parabacteroides
WO2018112365A2 (en) 2016-12-16 2018-06-21 Evelo Biosciences, Inc. Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
PL3600363T3 (pl) * 2017-06-14 2021-06-14 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
TWI812624B (zh) * 2017-06-14 2023-08-21 南韓商希杰生物科技股份有限公司 包含細菌品系之組成物
SG11202011031UA (en) * 2018-05-11 2020-12-30 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2020120714A1 (en) * 2018-12-12 2020-06-18 4D Pharma Research Limited Compositions comprising bacterial strains
TW202038977A (zh) * 2018-12-12 2020-11-01 英商4D製藥研究有限公司 包含細菌菌株之組成物

Similar Documents

Publication Publication Date Title
JP2022088631A5 (https=)
JP2021523895A5 (https=)
Wang et al. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice
HRP20220578T1 (hr) Pripravci koji sadrže bakterijske sojeve
Alzahrani et al. Effect of Helicobacter pylori on gastric epithelial cells
AU2017200541B2 (en) Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
JP2018518974A5 (https=)
US10111927B2 (en) Pseudomonas exotoxin A with less immunogenic B cell epitopes
JP2019522973A5 (https=)
JPWO2019215345A5 (https=)
Sharma et al. Role of probiotics in the management of lung cancer and related diseases: An update
Fredriksen et al. Cell wall anchoring of the 37-kilodalton oncofetal antigen by Lactobacillus plantarum for mucosal cancer vaccine delivery
JP2010508847A5 (https=)
Chen et al. Gene polymorphisms of pathogenic Helicobacter pylori in patients with different types of gastrointestinal diseases
US20210254005A1 (en) Off-the-shelf stem cell and immune cell, and a pharmaceutical composition including the same
Han et al. Interleukin-32: Frenemy in cancer?
de Brito et al. Role of polymorphisms in genes that encode cytokines and Helicobacter pylori virulence factors in gastric carcinogenesis
Amedei et al. T cells in gastric cancer: friends or foes
Teng et al. Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastases
JP2018522041A5 (https=)
Ting et al. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer
de Souza Gonçalves et al. From Helicobacter pylori infection to gastric cancer: Current evidence on the immune response
Ghosh et al. Helicobacter pylori strains harboring babA2 from Indian sub population are associated with increased virulence in ex vivo study
AU2016311429C1 (en) Modified anthrax toxin protective antigen
EP4596678A1 (en) Engineered mesenchymal stem cell and use thereof